Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT00640718
Other study ID # ES-MRK-PROT1.1
Secondary ID
Status Withdrawn
Phase N/A
First received March 17, 2008
Last updated July 17, 2016
Start date March 2008
Est. completion date May 2010

Study information

Verified date March 2008
Source EarlySense Ltd.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The EverOn™ system developed by EarlySense, Ltd., the sponsor of this study, is intended to assist hospitals to better address and improve recognition and response to changes in a patient's condition.

The system, monitors the patient while in bed consists of a contact-free sensor that is placed under the bed mattress and identifies respiratory and heart rates, degree of patient's movement or agitation while in bed as well as patient's actual exit out of the bed. The EverOn system does not require a physical contact with the patient, eliminating the need for any direct contact electrodes, leads, cuffs or nasal cannulae.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date May 2010
Est. primary completion date March 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

1. Age above 18 years.

2. Patients not monitored continuously by telemetry, vital sign monitor or oximetry.

3. Patients not requiring special mattresses (e.g. airflow).

4. The patient or a legal guardian is ready to sign the Informed Consent.

Exclusion Criteria:

1. Patients that at the judgment of the staff in the evaluating unit, are not able to communicate coherently and respond to nurses' questions.

2. Patients monitored continuously by telemetry, vital sign monitor or oximetry.

3. Patients requiring special mattresses.

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Locations

Country Name City State
United States MetroWest Medical Center Framingham Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
EarlySense Ltd.

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT01904344 - Clinical Validation of New Breathing Sensors in Patients With Respiratory Insufficiency N/A